Advanced DNA-Enabled Antimicrobial Protection
Inolyt's DNA-stabilized silver nanoclusters are a new class of antimicrobials engineered at the molecular level to protect the surfaces conventional solutions fail to reliably defend.
Our Why?
Antimicrobial resistance (AMR) is a growing global challenge impacting healthcare, infrastructure, and environmental safety. Resistant pathogens contribute to contamination risks in hospitals, public spaces, and industrial settings.
5M
Deaths Annually
From antibiotic-resistant infections worldwide
136M
HAIs Per Year
Hospital-acquired infections caused by resistant pathogens
$100T
Projected Cost by 2050
Cumulative global economic burden of AMR
40M
Deaths/Year by 2050
Without new antimicrobial therapies
DNA-Stabilized Silver Nanoclusters (DNA-AgNCs)
Our breakthrough technology combines the antimicrobial power of silver with the programmability and biocompatibility of DNA. Unlike conventional silver nanoparticles, DNA-AgNCs contain only a few silver atoms per cluster — yet deliver dramatically superior antimicrobial performance.
- Demonstrated enhanced antimicrobial activity compared to conventional silver formulations*
- DNA-enabled structure allows tunable physicochemical properties
- Designed for controlled antimicrobial activity on surfaces
- Green synthesis — no harsh chemicals or energy-intensive processes
Multi-Pathway Activity
Membrane disruption and ROS generation via multiple simultaneous mechanisms — reducing the likelihood of resistance development.
Controlled Activity
Designed for targeted antimicrobial activity on surfaces with a favorable physicochemical profile.
Environmentally Safe
Rapid degradation with no accumulation in crops, soil, or water.
Easy Manufacturing
Shelf-stable, no cold chain, scalable production without specialized infrastructure.
Built-in Fluorescence
Intrinsic fluorescent properties enable real-time monitoring and confirmation of deployment.
DNA-Programmable
Tunable properties via DNA scaffold engineering for pathogen-specific targeting.
How We Compare
DNA-AgNCs outperform both traditional antibiotics and conventional silver nanoparticles across various critical dimensions.
| Feature | DNA-AgNCs | Antibiotics | Silver NPs |
|---|---|---|---|
| Broad Microbial Activity* | |||
| Multi-Pathway Mechanism | |||
| Reduced Resistance Risk (multi-mechanism)* | |||
| High Biocompatibility | |||
| Tunable / Programmable | |||
| Environmentally Safe | |||
| Shelf-Stable (No Cold Chain) | |||
| Built-in Fluorescence |
*Based on internal laboratory studies under controlled conditions. Results have not been evaluated by regulatory authorities.
One Platform. Endless Applications.
Our modular technology supports diverse surface protection formats — spanning healthcare, public environments, and industrial settings.
Hospital & Clinical Surface Cleaner
Antimicrobial surface solutions for healthcare facilities, operating rooms, and high-contact environments where contamination risk is highest.
Medical Device Surface Coatings
Coatings for non-implant medical devices, catheters, and surgical instruments to prevent biofilm formation and surface contamination.
High-Touch Environment Sanitation
Surface protection for public spaces, transportation, and commercial facilities where microbial contamination poses ongoing risk.
Industrial Cleaning Systems
Scalable antimicrobial formulations for industrial and commercial cleaning applications requiring durable, broad-spectrum surface protection.
Meet the Team
A multidisciplinary team of scientists, engineers, and business leaders united by a mission to defeat antimicrobial resistance.
Get in Touch
Interested in partnering or learning more? Send us a message and our team will respond promptly.